crossov comparison maximum dose glyburid glipizid patient non-insulin-depend diabet niddm maximum dose glyburid GB glipizid GZ trial altern second-gener sulfonylurea sg insulin therapi efficaci therapeut maneuv subject serum glucos fsg level mmol/l mg/dl maximum dose GB mg/day GZ mg/day group subject GB mean fsg mmol/l mg/dl group subject GZ mean fsg mmol/l mg/dl subject origin sg week maximum dose altern agent addit week valu fsg hemoglobin lipid studi week sg trial signific chang variabl group maximum dose GB therapi dose GZ therapi combin studi group advantag agent metabol control niddm patient maximum dose GB GZ altern sg 